UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy

Nature communications, 2018-02, Vol.9 (1), p.741-14, Article 741

2018

Volltextzugriff (PDF)

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

Journal of clinical oncology, 2017-10, Vol.35 (28), p.3240-3261

2017

Volltextzugriff (PDF)

Antiemetics: ASCO Guideline Update

Journal of clinical oncology, 2020-08, Vol.38 (24), p.2782-2797

2020

Volltextzugriff (PDF)

High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells

Cancer research (Chicago, Ill.), 2004-09, Vol.64 (17), p.6337-6343

2004

Volltextzugriff (PDF)

Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma

Science translational medicine, 2015-05, Vol.7 (288), p.288ra78

2015

Volltextzugriff (PDF)

Targeting Immune Suppression with PDE5 Inhibition in End-Stage Multiple Myeloma

Cancer immunology research, 2014-08, Vol.2 (8), p.725-731

2014

Volltextzugriff (PDF)

Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

The Journal of experimental medicine, 2006-11, Vol.203 (12), p.2691-2702

2006

Volltextzugriff (PDF)

Tadalafil augments tumor specific immunity in patients with head and neck squamous cell carcinoma

Clinical cancer research, 2015-01, Vol.21 (1), p.30-38

2015

Volltextzugriff (PDF)

A novel role of IL-17–producing lymphocytes in mediating lytic bone disease in multiple myeloma

Blood, 2010-11, Vol.116 (18), p.3554-3563

2010

Volltextzugriff (PDF)

Marrow-Infiltrating Lymphocytes - Role in Biology and Cancer Therapy

Frontiers in immunology, 2016-03, Vol.7, p.112-112

2016

Volltextzugriff (PDF)

An Allogeneic Multiple Myeloma GM-CSF-Secreting Vaccine with Lenalidomide Induces Long-term Immunity and Durable Clinical Responses in Patients in Near Complete Remission

Clinical cancer research, 2021-12, Vol.27 (24), p.6696-6708

2021

Volltextzugriff (PDF)

Consensus Recommendations for the Clinical Management of Patients With Multiple Myeloma Treated With Selinexor

Clinical lymphoma, myeloma and leukemia, 2020-06, Vol.20 (6), p.351-357

2020

Volltextzugriff (PDF)

Flow cytometric discrimination of seven lineage markers by using two fluorochromes

PloS one, 2017-11, Vol.12 (11), p.e0188916-e0188916

2017

Volltextzugriff (PDF)

Marrow Infiltrating Lymphocytes: Their Role in Adoptive Immunotherapy

The cancer journal (Sudbury, Mass.), 2015-11, Vol.21 (6), p.501-505

2015

Volltextzugriff (PDF)

Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy

Journal of translational medicine, 2017-07, Vol.15 (1), p.155-155, Article 155

2017

Volltextzugriff (PDF)

Correction: Tadalafil Augments Tumor-specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma

Clinical cancer research, 2018-12, Vol.24 (23), p.6100-6100

2018

Volltextzugriff (PDF)

Myeloid-Derived Suppressor Cells Promote Cross-Tolerance in B-Cell Lymphoma by Expanding Regulatory T Cells

Cancer research (Chicago, Ill.), 2008-07, Vol.68 (13), p.5439-5449

2008

Volltextzugriff (PDF)

154 Marrow-infiltrating lymphocytes (MILs): A novel adoptive immunotherapy for hematological and solid tumors

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A93-A93

2020

Volltextzugriff (PDF)

Immunomodulatory Agents and Proteasome Inhibitors in the Treatment of Multiple Myeloma

Seminars in oncology nursing, 2017-08, Vol.33 (3), p.279-291

2017

Volltextzugriff (PDF)

NSP-12 Multiple myeloma and disparate populations: the path forward

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S319-S319

2023

Volltextzugriff (PDF)

The Immune Microenvironment of Myeloma

Cancer microenvironment, 2011-12, Vol.4 (3), p.313-323

2011

Volltextzugriff (PDF)

Management of myeloma-associated renal dysfunction in the era of novel therapies

Expert Review of Hematology, 2012-02, Vol.5 (1), p.51-68

2012

Volltextzugriff (PDF)

Activated Allogeneic Donor-derived Marrow-infiltrating Lymphocytes Display Measurable In Vitro Antitumor Activity

Journal of immunotherapy (1997), 2019-04, Vol.42 (3), p.73-80

2019

Volltextzugriff (PDF)

NSP-07 A comparison of reach and effectiveness of live versus virtual case-based education for nurses

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S316-S317

2023

Volltextzugriff (PDF)

Lenalidomide-Induced Immunomodulation in Multiple Myeloma: Impact on Vaccines and Antitumor Responses

Clinical cancer research, 2012-03, Vol.18 (5), p.1426-1434

2012

Volltextzugriff (PDF)

1 – 25 von 107

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(89)

Publikationsform

Sprache

Englisch
(107)

Erscheinungsjahr

n.n

Thema

Science & Technology
(57)
Life Sciences & Biomedicine
(51)
Humans
(43)
Oncology
(24)
Female
(20)
Male
(18)
Middle Aged
(15)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Multiple Myeloma
(13)
Bone Marrow
(11)
Hematology
(11)
Adult
(10)
Nursing
(10)
Multiple Myeloma - Drug Therapy
(9)
Aged
(8)
Tumors
(8)
Animals
(7)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Mice
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

Antiemetics: ASCO Guideline Update

High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells

Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma

Targeting Immune Suppression with PDE5 Inhibition in End-Stage Multiple Myeloma

Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

Tadalafil augments tumor specific immunity in patients with head and neck squamous cell carcinoma

A novel role of IL-17–producing lymphocytes in mediating lytic bone disease in multiple myeloma

Marrow-Infiltrating Lymphocytes - Role in Biology and Cancer Therapy

An Allogeneic Multiple Myeloma GM-CSF-Secreting Vaccine with Lenalidomide Induces Long-term Immunity and Durable Clinical Responses in Patients in Near Complete Remission

Consensus Recommendations for the Clinical Management of Patients With Multiple Myeloma Treated With Selinexor

Flow cytometric discrimination of seven lineage markers by using two fluorochromes

Marrow Infiltrating Lymphocytes: Their Role in Adoptive Immunotherapy

Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy

Correction: Tadalafil Augments Tumor-specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma

Myeloid-Derived Suppressor Cells Promote Cross-Tolerance in B-Cell Lymphoma by Expanding Regulatory T Cells

154 Marrow-infiltrating lymphocytes (MILs): A novel adoptive immunotherapy for hematological and solid tumors

Immunomodulatory Agents and Proteasome Inhibitors in the Treatment of Multiple Myeloma

NSP-12 Multiple myeloma and disparate populations: the path forward

The Immune Microenvironment of Myeloma

Management of myeloma-associated renal dysfunction in the era of novel therapies

Activated Allogeneic Donor-derived Marrow-infiltrating Lymphocytes Display Measurable In Vitro Antitumor Activity

NSP-07 A comparison of reach and effectiveness of live versus virtual case-based education for nurses

Lenalidomide-Induced Immunomodulation in Multiple Myeloma: Impact on Vaccines and Antitumor Responses

Suchergebnisse filtern